Sensus Healthcare Inc. (SRTS)
Sensus Healthcare Statistics
Share Statistics
Sensus Healthcare has 16.5M shares outstanding. The number of shares has increased by 0.63% in one year.
Shares Outstanding | 16.5M |
Shares Change (YoY) | 0.63% |
Shares Change (QoQ) | 0.64% |
Owned by Institutions (%) | 30.05% |
Shares Floating | 13.55M |
Failed to Deliver (FTD) Shares | 199 |
FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 874.74K, so 5.34% of the outstanding shares have been sold short.
Short Interest | 874.74K |
Short % of Shares Out | 5.34% |
Short % of Float | 5.89% |
Short Ratio (days to cover) | 6.46 |
Valuation Ratios
The PE ratio is 16.98 and the forward PE ratio is 7.14. Sensus Healthcare's PEG ratio is 0.01.
PE Ratio | 16.98 |
Forward PE | 7.14 |
PS Ratio | 2.7 |
Forward PS | 0.9 |
PB Ratio | 2.02 |
P/FCF Ratio | -101.97 |
PEG Ratio | 0.01 |
Enterprise Valuation
Sensus Healthcare has an Enterprise Value (EV) of 91.43M.
EV / Sales | 2.19 |
EV / EBITDA | 11.3 |
EV / EBIT | -110.02 |
EV / FCF | -82.59 |
Financial Position
The company has a current ratio of 9.64, with a Debt / Equity ratio of 0.01.
Current Ratio | 9.64 |
Quick Ratio | 7.93 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.07 |
Debt / FCF | -0.54 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 11.91% and Return on Invested Capital is 10.55%.
Return on Equity | 11.91% |
Return on Assets | 10.69% |
Return on Invested Capital | 10.55% |
Revenue Per Employee | $774.2K |
Profits Per Employee | $123.09K |
Employee Count | 54 |
Asset Turnover | 0.67 |
Inventory Turnover | 1.72 |
Taxes
Income Tax | 2.38M |
Effective Tax Rate | 26.32% |
Stock Price Statistics
The stock price has increased by 18.84% in the last 52 weeks. The beta is 1.11, so Sensus Healthcare's price volatility has been higher than the market average.
Beta | 1.11 |
52-Week Price Change | 18.84% |
50-Day Moving Average | 4.72 |
200-Day Moving Average | 6.28 |
Relative Strength Index (RSI) | 38.01 |
Average Volume (20 Days) | 271.42K |
Income Statement
In the last 12 months, Sensus Healthcare had revenue of 41.81M and earned 6.65M in profits. Earnings per share was 0.41.
Revenue | 41.81M |
Gross Profit | 24.43M |
Operating Income | 8.09M |
Net Income | 6.65M |
EBITDA | 8.09M |
EBIT | 8.09M |
Earnings Per Share (EPS) | 0.41 |
Balance Sheet
The company has 22.06M in cash and 602K in debt, giving a net cash position of 21.45M.
Cash & Cash Equivalents | 22.06M |
Total Debt | 602K |
Net Cash | 21.45M |
Retained Earnings | 13.43M |
Total Assets | 62.16M |
Working Capital | 50.85M |
Cash Flow
In the last 12 months, operating cash flow was -831K and capital expenditures -276K, giving a free cash flow of -1.11M.
Operating Cash Flow | -831K |
Capital Expenditures | -276K |
Free Cash Flow | -1.11M |
FCF Per Share | -0.07 |
Margins
Gross margin is 58.44%, with operating and profit margins of 19.35% and 15.9%.
Gross Margin | 58.44% |
Operating Margin | 19.35% |
Pretax Margin | 21.58% |
Profit Margin | 15.9% |
EBITDA Margin | 19.35% |
EBIT Margin | 19.35% |
FCF Margin | -2.65% |
Dividends & Yields
SRTS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 5.89% |
FCF Yield | -0.98% |
Analyst Forecast
The average price target for SRTS is $13, which is 203% higher than the current price. The consensus rating is "Buy".
Price Target | $13 |
Price Target Difference | 203% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Scores
Altman Z-Score | 9.78 |
Piotroski F-Score | 3 |